A systematic comparison of optogenetic approaches to visual restoration.
A systematic comparison of optogenetic approaches to visual restoration.
复制标题
DOI:
10.1016/j.omtm.2022.03.003
复制
发表时间:
2022-06-09
期刊:
影响因子:
--
通讯作者:
Hankins MW
中科院分区:
文献类型:
--
作者:
Gilhooley MJ;Lindner M;Palumaa T;Hughes S;Peirson SN;Hankins MW
During inherited retinal degenerations (IRDs), vision is lost due to photoreceptor cell death; however, a range of optogenetic tools have been shown to restore light responses in animal models. Restored response characteristics vary between tools and the neuronal cell population to which they are delivered: the interplay between these is complex, but targeting upstream neurons (such as retinal bipolar cells) may provide functional benefit by retaining intraretinal signal processing. In this study, our aim was to compare two optogenetic tools: mammalian melanopsin (hOPN4) and microbial red-shifted channelrhodopsin (ReaChR) expressed within two subpopulations of surviving cells in a degenerate retina. Intravitreal adeno-associated viral vectors and mouse models utilising the Cre/lox system restricted expression to populations dominated by bipolar cells or retinal ganglion cells and was compared with non-targeted delivery using the chicken beta actin (CBA) promoter. In summary, we found bipolar-targeted optogenetic tools produced faster kinetics and flatter intensity-response relationships compared with non-targeted or retinal-ganglion-cell-targeted hOPN4. Hence, optogenetic tools of both mammalian and microbial origins show advantages when targeted to bipolar cells. This demonstrates the advantage of bipolar-cell-targeted optogenetics for vision restoration in IRDs. We therefore developed a bipolar-cell-specific gene delivery system employing a compressed promoter with the potential for clinical translation. Optogenetics represents a promising potential therapeutic option in the inherited retinal degenerations; which optogenetic tool or target cell population will be most effective is, however, unknown. This study, for the first time, directly compares potential tools and delivery routes in a retinal degenerate mouse model.
登录
查看更多内容
影响因子:
2.9
作者:
Blasic, Joseph R., Jr.;Matos-Cruz, Vanessa;Robinson, Phyllis R.
通讯作者:
Robinson, Phyllis R.
影响因子:
3.3
作者:
Ivanova, E.;Hwang, G. -S.;Pan, Z. -H.
通讯作者:
Pan, Z. -H.
影响因子:
11.1
作者:
Cronin T;Vandenberghe LH;Hantz P;Juttner J;Reimann A;Kacsó AE;Huckfeldt RM;Busskamp V;Kohler H;Lagali PS;Roska B;Bennett J
通讯作者:
Bennett J
影响因子:
8
作者:
Hughes, Steven;Jagannath, Aarti;Hankins, Mark W.
通讯作者:
Hankins, Mark W.
DOI:
10.1038/mtm.2013.5
发表时间:
2014-01-08
期刊:
Molecular therapy. Methods & clinical development
影响因子:
--
作者:
通讯作者:
--